Press release
Global Methicillin-Resistant Staphylococcus Aureus Drugs Industry 2018 Market Research Report, Popular Trends & Technological Advancements, Forecast & Opportunities
Methicillin-Resistant Staphylococcus Aureus Drugs
The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encourage the expansion of the Methicillin-Resistant Staphylococcus Aureus Drugs Market during the said period. The report also provides market attractiveness analysis, by geography, and market share analysis, by key players respectively. Some of the prominent participants in the Global Methicillin-Resistant Staphylococcus Aureus Drugs Market are Theravance Biopharma, Basilea Pharmaceutica, Pfizer, Debiopharm Group, Merck, Allergan, Melinta Therapeutics, AmpliPhi Biosciences Corporation, KYORIN Pharmaceutical Co. Ltd. and Baxter International.
For More Details Get Free Sample Pages of this Research Report@ https://www.infiniumglobalresearch.com/reports/sample-request/1187
The report also identifies the drivers and restraints that affect the Methicillin-Resistant Staphylococcus Aureus Drugs market over the period of 2018 to 2024.
Increased funding for antibiotic research
Increased funding for antibiotic research and patient assistance programs are the recent market trends in the global Methicillin-Resistant Staphylococcus Aureus Drugs market. Moreover, this trend is further anticipated to drive the global Methicillin-Resistant Staphylococcus Aureus Drugs market over the forecast period. Furthermore, the growing patient pool of low income and uninsured patients, as well as high unmet needs in the market, are the key factors responsible for the increased funding for antibiotic research and patient assistance programs.
Growing incidences of infections and rising aging population
Growing incidences of infections and rising aging population are the key factor responsible for the growth of global Methicillin-Resistant Staphylococcus Aureus Drugs market. Moreover, high contagious nature of this infection and difficulties in treatment due to its resistance to commonly used antibiotics such as methicillin is the key factor responsible for the growth of growing incidences of infections. Furthermore, the aging population are easily prone to infections and diseases across hospitals and healthcare facilities owing to their weak immune systems.
North America region is the largest consumer among the geographies followed by Europe while APAC to grow at the highest CAGR
The global Methicillin-Resistant Staphylococcus Aureus Drugs market has been dominated by the North America region over the historic period 2015-16 followed by Europe. Presence of developed healthcare infrastructure coupled with co-pay assistance programs for patients and rising initiatives for the approval of new antibiotics owing to favorable regulations are the prime factor responsible for the growth of Methicillin-Resistant Staphylococcus Aureus Drugs market in this region. Furthermore, the Asia-Pacific region is expected to grow at the highest CAGR over the period of 2018 to 2024. Moreover, raising awareness among the population about the antibiotic-resistant bacterial infections and growing incidences of hospital-acquired disease in the developing economies are anticipated to boost the market for Methicillin-Resistant Staphylococcus Aureus Drugs.
Purchase Global Methicillin-Resistant Staphylococcus Aureus Drugs market by drug class (cephalosporin, lipopeptides, lipoglycopeptide, folate antagonist, tetracycline and oxazolidinone), by MOA (bactericidal drugs and bacteriostatic), by drug origin (synthetic drugs and semisynthetic) and by region (North America, Europe, Asia Pacific, Latin America and RoW) report on https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-methicillin-resistant-staphylococcus-aureus-drugs-market
Major Key Players Mentioned in this Premium Report@
The companies covered in the report include Theravance Biopharma, Basilea Pharmaceutica, Pfizer, Debiopharm Group, Merck, Allergan, Melinta Therapeutics, AmpliPhi Biosciences Corporation, KYORIN Pharmaceutical Co. Ltd. and Baxter International.
Reasons to buy this report
Comprehensive analysis of global as well as regional markets of Methicillin-Resistant Staphylococcus Aureus Drugs
Complete coverage of all the product type and applications segments to analyze the trends, developments, and forecast of market size up to 2024.
Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and the latest developments of the company.
Infinium Global Research- Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
Infinium Global Research and Consulting Solutions is started with a single motto of being a business partner of the first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you. With our strategic research approaches and deep dive in the market segments, we try to find out new opportunities that our clients can encash with their existing resources. Our experts with over 100 years of cumulative experience in research offer the best in the industry services to our clients to ensure that they achieve their business goals.
Infinium Global Research
Office No. 04, 06, Ganadhish Empire,
Rahatani Corner, Pune, MH 411027
Email: info@infiniumglobalresearch.com
Website: www.infiniumglobalresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Methicillin-Resistant Staphylococcus Aureus Drugs Industry 2018 Market Research Report, Popular Trends & Technological Advancements, Forecast & Opportunities here
News-ID: 1695715 • Views: …
More Releases from Infinium Global Research
Sustainable Aviation Fuel (SAF) Market Growth Outlook Strong with USD 5000 Milli …
The global sustainable aviation fuel (SAF) market is witnessing an unprecedented surge, growing from nearly USD 290 million in 2022 to over USD 5,000 million by 2028, at a remarkable CAGR of more than 60%. This rapid expansion highlights the industry's strong commitment to decarbonizing aviation, which remains one of the most carbon-intensive transportation sectors. SAF, produced from renewable resources such as waste oils, agricultural residues, municipal waste, and biomass,…
Automotive Windshield Market Size to Expand from USD 17.49 Bn in 2023 to USD 30. …
The global automotive windshield market is one of the most essential components of the automotive industry, ensuring both passenger safety and driver visibility. Valued at USD 17.49 billion in 2023, the market is projected to reach USD 30.84 billion by 2032, expanding at a CAGR of 6.53% from 2024 to 2032. Windshields are no longer just protective glass panels; they have evolved into high-performance safety components incorporating advanced technologies such…
Satellite Communication Equipment Market Poised for USD 44 Bn by 2032
The global satellite communication (SATCOM) equipment market is undergoing rapid expansion, fueled by the increasing need for reliable connectivity across diverse applications. Valued at approximately USD 20 billion in 2023, the market is forecasted to nearly double, reaching USD 44 billion by 2032, registering a CAGR of almost 10% during 2024-2032. SATCOM equipment, comprising receivers, antennas, transponders, and transceivers, plays a critical role in enabling long-distance communication for both commercial…
Solar Vehicle Market Growth Outlook Strong with USD 6.25B Valuation by 2032
The global solar vehicle market is rapidly emerging as one of the most promising segments in sustainable mobility. Valued at USD 331.68 million in 2023, the market is expected to surge to USD 6,255.20 million by 2032, expanding at an impressive CAGR of 38.63% from 2024 to 2032. This unprecedented growth reflects the convergence of rising environmental concerns, government initiatives, and technological breakthroughs in solar panel and battery efficiency. Solar…
More Releases for Staphylococcus
Rise In Prevalence Of Methicillin-Resistant Staphylococcus Aureus Infections: Po …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Through 2025?
In recent times, the market size of drugs for methicillin-resistant staphylococcus aureus (MRSA) has seen continuous growth. The market, which was worth $2.35 billion in 2024, is projected to expand to $2.47 billion in…
Leading Growth Driver in the Methicillin-Resistant Staphylococcus Aureus (MRSA) …
What market dynamics are playing a key role in accelerating the growth of the methicillin-resistant staphylococcus aureus (mrsa) drugs market?
The growth of the methicillin-resistant Staphylococcus aureus drugs market is expected to be fuelled by the rise in Hospital Acquired Infections (HAIs). Patients acquire these infections while being treated at a healthcare center, usually 48 hours or more post admissions. The root causes behind HAIs include contaminated medical apparatus, lax hand…
Staphylococcus Aureus Testing Market In-Depth Market Research Report 2027
A wide range of human clinical infection caused by Staphylococcus Aureus such as Skin, soft tissue, bacteremia, infective endocarditis and others are the major infection caused by Staphylococcus Aureus. The increased use of Staphylococcus Aureus testing in the diagnosis of staph infection grow rapidly, due to the availability of the various advanced test to screen the pathogen efficiently. There is a number of tests present in the market for Staphylococcus…
Methicillin-resistant Staphylococcus Aureus Therapeutics Pipeline Analysis 2018
MRSA infection caused by specific "staph" bacteria that is often resistant to most of antibiotic treatments. S. aureus (SA) is listed as a ‘superbug’ by U.S. Centers for Disease Control and Prevention (CDC). MRSA can either be present harmlessly on the skin (colonization) or enter the body (e.g. through broken skin) and cause an infection. The study analyzed that MRSA infection therapeutics pipeline comprises approximately 52 drug candidates in different…
Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market – Driver
Methicillin-Resistant Staphylococcus Aureus (MRSA) is a type of staphylococcus aureus, which became resistant to methicillin, amoxicillin, penicillin, oxacillin, and other such commonly used antibiotics. Staphylococcus aureus harbors on the skin and nasal passage of about one third of the world population, which comprises around 33%, as per Centers for Disease Control and Prevention (CDC) review 2015. MRSA can be classified into two types, based on mode of infection – Hospital…
Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Maufacturing Cos …
Qyresearchreports include new market research report "Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs Market Size, Status and Forecast 2022" to its huge collection of research reports.
The global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market is exhibiting steady growth amidst a dynamic business environment. The report is compiled to identify key growth avenues of the global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drugs market and challenges that pose threat to its expansion goals. It also…
